Literature DB >> 1719944

Conization for CIN associated with human papillomavirus infection.

M Yliskoski1, S Saarikoski, K Syrjänen.   

Abstract

We report results of follow-up by PAP smears and colposcopy in 116 women treated since 1981 by conization for cervical intraepithelial neoplasia with human papillomavirus infection (HPV-CIN). The mean follow-up time was 31.9 (SD 19) months. Preoperative diagnosis was HPV-CIN II (with extension into the endocervix) in 11 cases and HPV-CIN III in 103 cases; two diagnostic conizations were performed. The histological examination of the cone biopsies showed complete excision of CIN in 109 cases (94%). Three patients underwent hysterectomy after conization; one had microinvasion in the cone biopsy, one had suspicion of microinvasion and one had non-radical conization. Three patients (2.6%) were lost to follow-up. After excluding these six patients the primary cure rate of HPV lesions (normal cytological and colposcopical finding after conization) was 82.7%. Four patients (4.6%) had residual CIN after conization. During the follow-up 15 patients had recurrence of HPV infection, only one had HPV-CIN I. HPV 16 was the most common HPV type (56/116, 48.2%) in the conization group and also in the recurrent cases (9/15, 60%). The results support the role of HPV 16 in cervical carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719944     DOI: 10.1007/bf02390363

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  22 in total

1.  The accuracy of colposcopically directed biopsy in diagnosis of CIN.

Authors:  T J Helmerhorst; G H Dijkhuizen; J J Calame; H J Kwikkel; J G Stolk
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1987-03       Impact factor: 2.435

2.  Conization for preinvasive and early invasive carcinoma of the uterine cervix.

Authors:  G Larsson
Journal:  Acta Obstet Gynecol Scand Suppl       Date:  1983

3.  Conization as treatment of carcinoma in situ of the uterine cervix.

Authors:  M Ahlgren; I Ingemarsson; L G Lindberg; R B Nordqvist
Journal:  Obstet Gynecol       Date:  1975-08       Impact factor: 7.661

4.  [CO2 laser therapy and typing of human papilloma virus in follow-up studies of cervix intraepithelial neoplasms].

Authors:  A Göppinger; H Ikenberg; G Birmelin; M Hilgarth; A Pfleiderer; H G Hillemanns
Journal:  Geburtshilfe Frauenheilkd       Date:  1988-05       Impact factor: 2.915

5.  Prospective follow-up of genital HPV infections: survival analysis of the HPV typing data.

Authors:  V Kataja; K Syrjänen; S Syrjänen; R Mäntyjärvi; M Yliskoski; S Saarikoski; J T Salonen
Journal:  Eur J Epidemiol       Date:  1990-03       Impact factor: 8.082

6.  Cryotherapy and CO2-laser vaporization in the treatment of cervical and vaginal human papillomavirus (HPV) infections.

Authors:  M Yliskoski; S Saarikoski; K Syrjänen; S Syrjänen; O Castrén
Journal:  Acta Obstet Gynecol Scand       Date:  1989       Impact factor: 3.636

7.  Invasive cancer of the cervix after laser treatment.

Authors:  S E Pearson; J Whittaker; D Ireland; J M Monaghan
Journal:  Br J Obstet Gynaecol       Date:  1989-04

8.  The treatment of grade 3 cervical intraepithelial neoplasia with cryotherapy: an 11-year experience.

Authors:  S C Bryson; P Lenehan; G M Lickrish
Journal:  Am J Obstet Gynecol       Date:  1985-01-15       Impact factor: 8.661

9.  Sensitivity of in situ hybridization techniques using biotin- and 35S-labeled human papillomavirus (HPV) DNA probes.

Authors:  S Syrjänen; P Partanen; R Mäntyjärvi; K Syrjänen
Journal:  J Virol Methods       Date:  1988 Mar-Apr       Impact factor: 2.014

10.  Laser excision rather than vaporization: the treatment of choice for cervical intraepithelial neoplasia.

Authors:  G A McIndoe; M S Robson; J A Tidy; W P Mason; M C Anderson
Journal:  Obstet Gynecol       Date:  1989-08       Impact factor: 7.661

View more
  1 in total

1.  Periodic health examination, 1995 update: 1. Screening for human papillomavirus infection in asymptomatic women. Canadian Task Force on the Periodic Health Examination.

Authors:  K Johnson
Journal:  CMAJ       Date:  1995-02-15       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.